Neofox-arkiv - BioStock

BioInvent BT-001

WntResearch recruits first patient in restart of NeoFox

20 October, 2023

New study plan approved for WntResearch’s phase II study

14 July, 2023

WntResearchs vd om optionsprogrammet och NeoFox-studien

WntResearch’s CEO on the option program and the NeoFox study

27 March, 2023

WntResearch om den uppdaterade studieplanen för NeoFox-studien

WntResearch on the revised study plan for the NeoFox-study

9 December, 2022

WntResearch's CEO Pernilla Sandwall

BioStock Investor Meeting: Interview with WntResearch

28 September, 2022

WntResearch fortsätter rekrytera, bland annat ny VD

New CEO and continued patient recruitment for WntResearch

22 February, 2022

WntResearchs drug candidate shows potential in leukemia

WntResearch’s Foxy-5 shows potential in leukaemia

4 January, 2022

WntResarch will focus on recruitment

WntResearch to focus on patient recruitment

7 December, 2021

Rekrytering i fokus för WntResearch

WntResearch focuses on recruitment of patients and new CEO

9 September, 2021

WntResearch reaches full operations again in NeoFox study

7 July, 2021

12 Page 1 of 2